SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don Hurst who wrote (182)12/12/1997 5:22:00 PM
From: Easy Mark   of 1510
 
It may be related to the Science article by Bruce Walker. This is what IRC said in a press release on Dec 4:
"A recent publication in "Science" (November 21) reports on the
importance of maintaining a virus-specific CD4 and T helper cell response in
HIV infection. Specifically, Dr. Bruce Walker and his colleagues at Harvard
showed there was a direct correlation between HIV-specific T cell
proliferation and the successful control of virus replication in the absence
of antiviral drug therapy in certain HIV-infected individuals. Dr. Walker and
other researchers believe the new results provide some hope that these T
helper cells could be boosted even in people who show little evidence of
having them, possibly by combining powerful antiviral therapies with anti-HIV
therapeutic vaccines. In our most recent published studies, we have shown
that the administration of REMUNE to HIV-infected individuals elicits not only
HIV-specific T cell proliferation, but also induces chemokines and gamma
interferon along with a reduction in tumor necrosis factor, all of which are
believed by scientists to have a favorable impact on disease progression."
You can read a more detailed article by Stanley Moss (of IRC) at
207.226.163.175.
If anyone can interpret the sci-fi jargon in either statement, please elucidate.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News